{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "G",
                    "position": "1441"
                },
                "variant_string_id": "LRRK2 R1441G"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Mutations in Leucine - Rich Repeat Kinase 2 (LRRK2) have been linked to the most common familial form and some sporadic forms of Parkinson's disease (PD). The pathogenic mechanism of PD remains largely undefined, but an understanding of LRRK2 biology and pathophysiology may provide new treatment opportunities. LRRK2 has kinase and GTPase activities, and PD - linked mutations may alter these activities, leading to a 'gain - of - function' hypothesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly links LRRK2 mutations to PD and hypothesizes about the role of LRRK2's activities in the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study investigated phosphorylation sites, binding proteins of LRRK2, and the effect of PD - related mutations on these processes. Assays included affinity purification, mass spectrometric analysis, immunoprecipitation, GST - pull down assay, and kinase assay.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to studying the molecular mechanisms related to LRRK2 function and how PD - related mutations affect it, which is in line with the defined disease mechanism of PD related to LRRK2.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": ""
                },
                {
                    "step_name": "Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "The Western blot signals were quantified by using LI - COR and Odyssey software. Data are presented as mean value (6 SEM) from three mice in some experiments. In kinase assays, multiple conditions with different concentrations of reagents were tested. Co - immunoprecipitation and GST - pull down assays were also repeated in multiple independent experiments.",
                    "judgment": "Yes",
                    "reasoning": "The use of mean values with SEM from multiple mice and multiple independent experiments for various assays indicates the use of replicates. Also, the use of non - transgenic controls in affinity purification and wild - type and mutant comparisons in other assays suggest the use of basic controls.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "The study compared the effects of PD - related mutations (R1441G, Y1699C, G2019S) with wild - type LRRK2 in terms of phosphorylation levels of S935 and 14 - 3 - 3 binding. These PD - related mutations can be considered as variant controls.",
                    "judgment": "Yes",
                    "reasoning": "The PD - related mutations being compared to wild - type serve as variant controls as they help in understanding the impact of these mutations on LRRK2 function.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": ""
                },
                {
                    "step_name": "Sub - step 4a: Statistical Analyses",
                    "extracted_paper_info": "The data was analyzed by One - way ANOVA (** P,0.01).",
                    "judgment": "Yes",
                    "reasoning": "The use of One - way ANOVA indicates that statistical analyses were performed, which could potentially be used to estimate or calculate OddsPath for the functional data.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The paper does not directly provide an OddsPath value. However, based on the significant P - values from ANOVA, there is an indication of a significant effect of the R1441G mutation on phosphorylation levels of S935 and 14 - 3 - 3 binding. But without a direct OddsPath calculation, we cannot precisely assign a strength based on OddsPath thresholds.",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": "Since no OddsPath value is given, we consider the evidence strength based on the presence of variant controls and replicates. Given the use of multiple independent experiments and variant controls, and the significant statistical results, we can assign a moderate strength."
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The R1441G variant in LRRK2 was studied in the context of PD pathogenesis. The disease mechanism was defined, and the assays used were applicable. Basic controls, replicates, and variant controls were used. Statistical analyses were performed, although an OddsPath value was not directly provided. Based on the overall experimental setup and significant results, a PS3_moderate strength was assigned as the functional evidence indicates a likely pathogenic effect on LRRK2 function related to PD."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "Y",
                    "alt": "C",
                    "position": "1699"
                },
                "variant_string_id": "LRRK2 Y1699C"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Mutations in Leucine - Rich Repeat Kinase 2 (LRRK2) have been linked to the most common familial form and some sporadic forms of Parkinson's disease (PD). The pathogenic mechanism of PD remains largely undefined, but an understanding of LRRK2 biology and pathophysiology may provide new treatment opportunities. LRRK2 has kinase and GTPase activities, and PD - linked mutations may alter these activities, leading to a 'gain - of - function' hypothesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly links LRRK2 mutations to PD and hypothesizes about the role of LRRK2's activities in the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study investigated phosphorylation sites, binding proteins of LRRK2, and the effect of PD - related mutations on these processes. Assays included affinity purification, mass spectrometric analysis, immunoprecipitation, GST - pull down assay, and kinase assay.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to studying the molecular mechanisms related to LRRK2 function and how PD - related mutations affect it, which is in line with the defined disease mechanism of PD related to LRRK2.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": ""
                },
                {
                    "step_name": "Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "The Western blot signals were quantified by using LI - COR and Odyssey software. Data are presented as mean value (6 SEM) from three mice in some experiments. In kinase assays, multiple conditions with different concentrations of reagents were tested. Co - immunoprecipitation and GST - pull down assays were also repeated in multiple independent experiments.",
                    "judgment": "Yes",
                    "reasoning": "The use of mean values with SEM from multiple mice and multiple independent experiments for various assays indicates the use of replicates. Also, the use of non - transgenic controls in affinity purification and wild - type and mutant comparisons in other assays suggest the use of basic controls.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "The study compared the effects of PD - related mutations (R1441G, Y1699C, G2019S) with wild - type LRRK2 in terms of phosphorylation levels of S935 and 14 - 3 - 3 binding. These PD - related mutations can be considered as variant controls.",
                    "judgment": "Yes",
                    "reasoning": "The PD - related mutations being compared to wild - type serve as variant controls as they help in understanding the impact of these mutations on LRRK2 function.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": ""
                },
                {
                    "step_name": "Sub - step 4a: Statistical Analyses",
                    "extracted_paper_info": "The data was analyzed by One - way ANOVA (** P,0.01).",
                    "judgment": "Yes",
                    "reasoning": "The use of One - way ANOVA indicates that statistical analyses were performed, which could potentially be used to estimate or calculate OddsPath for the functional data.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The paper does not directly provide an OddsPath value. However, based on the significant P - values from ANOVA, there is an indication of a significant effect of the Y1699C mutation on phosphorylation levels of S935 and 14 - 3 - 3 binding. But without a direct OddsPath calculation, we cannot precisely assign a strength based on OddsPath thresholds.",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": "Since no OddsPath value is given, we consider the evidence strength based on the presence of variant controls and replicates. Given the use of multiple independent experiments and variant controls, and the significant statistical results, we can assign a moderate strength."
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The Y1699C variant in LRRK2 was studied in the context of PD pathogenesis. The disease mechanism was defined, and the assays used were applicable. Basic controls, replicates, and variant controls were used. Statistical analyses were performed, although an OddsPath value was not directly provided. Based on the overall experimental setup and significant results, a PS3_moderate strength was assigned as the functional evidence indicates a likely pathogenic effect on LRRK2 function related to PD."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "S",
                    "position": "2019"
                },
                "variant_string_id": "LRRK2 G2019S"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Mutations in Leucine - Rich Repeat Kinase 2 (LRRK2) have been linked to the most common familial form and some sporadic forms of Parkinson's disease (PD). The pathogenic mechanism of PD remains largely undefined, but an understanding of LRRK2 biology and pathophysiology may provide new treatment opportunities. LRRK2 has kinase and GTPase activities, and PD - linked mutations may alter these activities, leading to a 'gain - of - function' hypothesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly links LRRK2 mutations to PD and hypothesizes about the role of LRRK2's activities in the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study investigated phosphorylation sites, binding proteins of LRRK2, and the effect of PD - related mutations on these processes. Assays included affinity purification, mass spectrometric analysis, immunoprecipitation, GST - pull down assay, and kinase assay.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to studying the molecular mechanisms related to LRRK2 function and how PD - related mutations affect it, which is in line with the defined disease mechanism of PD related to LRRK2.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": ""
                },
                {
                    "step_name": "Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "The Western blot signals were quantified by using LI - COR and Odyssey software. Data are presented as mean value (6 SEM) from three mice in some experiments. In kinase assays, multiple conditions with different concentrations of reagents were tested. Co - immunoprecipitation and GST - pull down assays were also repeated in multiple independent experiments.",
                    "judgment": "Yes",
                    "reasoning": "The use of mean values with SEM from multiple mice and multiple independent experiments for various assays indicates the use of replicates. Also, the use of non - transgenic controls in affinity purification and wild - type and mutant comparisons in other assays suggest the use of basic controls.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "The study compared the effects of PD - related mutations (R1441G, Y1699C, G2019S) with wild - type LRRK2 in terms of phosphorylation levels of S935 and 14 - 3 - 3 binding. These PD - related mutations can be considered as variant controls.",
                    "judgment": "Yes",
                    "reasoning": "The PD - related mutations being compared to wild - type serve as variant controls as they help in understanding the impact of these mutations on LRRK2 function.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": ""
                },
                {
                    "step_name": "Sub - step 4a: Statistical Analyses",
                    "extracted_paper_info": "The data was analyzed by One - way ANOVA (** P,0.01).",
                    "judgment": "Yes",
                    "reasoning": "The use of One - way ANOVA indicates that statistical analyses were performed, which could potentially be used to estimate or calculate OddsPath for the functional data.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The paper does not directly provide an OddsPath value. The effect of G2019S on phosphorylation levels of S935 and 14 - 3 - 3 binding was modest and assay - dependent. Based on the significant P - values from ANOVA, there is some indication of an effect, but without a direct OddsPath calculation, we cannot precisely assign a strength based on OddsPath thresholds.",
                    "judgment": "",
                    "reasoning": "",
                    "next_step_or_outcome": "Since no OddsPath value is given, and the effect is modest and assay - dependent, considering the use of multiple independent experiments and variant controls, we assign a supporting strength."
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The G2019S variant in LRRK2 was studied in the context of PD pathogenesis.